Domov › Rak dojke › Ohio › Columbus

Klinične študije za Rak dojke v Columbus, OH

39 študij za Rak dojke išče udeležence na lokacijah v Columbus in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

Ohio State University Comprehensive Cancer Center, Columbus
Mount Carmel East Hospital, Columbus
The Mark H Zangmeister Center, Columbus
in še 8

Starost 40–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05334069

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

Vključevanje udeležencevFaza 2

The Ohio State University, Stefanie Spielman Comprehensive Breast Center, Columbus

Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06369285

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

Vključevanje udeležencevFaza 1

James Cancer Hospital and Solove Research Institute, Columbus

Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT06120283

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

Vključevanje udeležencevFaza 1/2

Local Institution - 0102, Columbus

Starost 18 in več · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT06618287

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Vključevanje udeležencevFaza 3

Clinical Trial Site, Columbus
Clinical Trial Site, Columbus

Starost 18 in več · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT07085767

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Vključevanje udeležencevFaza 3

The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07174336

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

Vključevanje udeležencevFaza 1

The Mark H. Zangmeister Center-Mid Ohio Oncology/Hematology, Inc., Columbus

Starost 18–55 · Ženske · Posodobljeno 9. sep. 2026 · NCT07310420

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

Vključevanje udeležencevFaza 1

The Ohio State University (OSU) Wexner Medical Center, Columbus

Starost 18 in več · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT06400472

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Vključevanje udeležencevFaza 3

Ohio State University Comprehensive Cancer Center, Columbus
Columbus Oncology and Hematology Associates Inc, Columbus
Riverside Methodist Hospital, Columbus
in še 8

Starost 18–60 · Ženske · Posodobljeno 2. sep. 2026 · NCT05879926

ATEMPT 2.0: Adjuvant T-DM1 vs TH

Vključevanje udeležencevFaza 2

Stefanie Spielman Comprehensive Breast Center, Columbus

Starost 18 in več · Vsi spoli · Posodobljeno 19. avg. 2026 · NCT04893109

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

Vključevanje udeležencevFaza 3

Ohio State University Comprehensive Cancer Center, Columbus

Starost 18 in več · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT06500481

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

Vključevanje udeležencevFaza 2Vabljeni zdravi prostovoljci

Ohio State University Comprehensive Cancer Center, Columbus

Starost 45–74 · Ženske · Posodobljeno 4. avg. 2026 · NCT06195306

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Vključevanje udeležencevFaza 1/2

Ohio State University Comprehensive Cancer Center (OSUCCC)- The James Cancer Hospital and Solove Research Institute, Columbus

Starost 18 in več · Vsi spoli · Posodobljeno 4. avg. 2026 · NCT05579366

E-Mindfulness Approaches for Living After Breast Cancer

Vključevanje udeležencevFaza 3

Ohio State University Comprehensive Cancer Center, Columbus
Mount Carmel East Hospital, Columbus
Mount Carmel Grove City Hospital, Grove City · 7 mi stran
in še 2

Starost 18–50 · Vsi spoli · Posodobljeno 4. avg. 2026 · NCT06748222

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Vključevanje udeležencevFaza 2

The Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus

Starost 8 in več · Vsi spoli · Posodobljeno 27. jul. 2026 · NCT05503797

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Vključevanje udeležencevFaza 1/2

Stefanie Spielman Comprehensive Breast Center, Columbus

Starost 18 in več · Vsi spoli · Posodobljeno 7. jul. 2026 · NCT05768139

Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)

Vključevanje udeležencevFaza 4

Ohio State University Comprehensive Cancer Center, Columbus

Starost 18 in več · Vsi spoli · Posodobljeno 7. jul. 2026 · NCT06169371

Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

Vključevanje udeležencevFaza 2

Ohio State University Comprehensive Cancer Center, Columbus

Starost 35 in več · Ženske · Posodobljeno 7. jul. 2026 · NCT05941520

A Pilot Study to Evaluate the Effectiveness of Focused Massage on Pain, Mobility, and Quality of Life During Radiation Treatment for Patients With Breast Cancer

Vključevanje udeležencev

The Ohio State University, Columbus

Starost 18 in več · Vsi spoli · Posodobljeno 2. jul. 2026 · NCT07447700

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

Vključevanje udeležencevFaza 3

The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solovev Research Institute (OSUCCC - , Columbus

Starost 18 in več · Vsi spoli · Posodobljeno 22. jun. 2026 · NCT05696626

Impact of Dietary Inflammatory Potential on Breast Cancer Risk

Vključevanje udeležencevOpazovalna študija

Ohio State University Comprehensive Cancer Center, Columbus

Starost 18 in več · Vsi spoli · Posodobljeno 12. jun. 2026 · NCT05178498

Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation

Vključevanje udeležencevFaza 1

Ohio State University-James Cancer Hospital and Solove Research Institute, Columbus

Starost 18 in več · Vsi spoli · Posodobljeno 8. jun. 2026 · NCT04890613

Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease

Vključevanje udeležencevFaza 2

Ohio State University, Stefanie Spielman Comprehensive Breast Center, Columbus

Starost 18 in več · Vsi spoli · Posodobljeno 1. jun. 2026 · NCT06875128

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

Vključevanje udeležencevFaza 3

Stefanie Spielman Comprehensive Breast Center at Olentangy River Road, Columbus

Starost 18 in več · Vsi spoli · Posodobljeno 18. maj 2026 · NCT06757634

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Vključevanje udeležencevFaza 2

The Ohio State University, Stefanie Spielman Comprehensive Breast Center, Columbus

Starost 18 in več · Vsi spoli · Posodobljeno 6. maj 2026 · NCT01042379

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

Vključevanje udeležencevFaza 2

Ohio State University Medical Center, Columbus

Starost 18 in več · Vsi spoli · Posodobljeno 29. apr. 2026 · NCT04468061

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Vključevanje udeležencevFaza 3

Ohio State University Comprehensive Cancer Center, Columbus
Mount Carmel East Hospital, Columbus
Riverside Methodist Hospital, Columbus
in še 8

Starost 50–70 · Vsi spoli · Posodobljeno 23. apr. 2026 · NCT04852887

Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients

Vključevanje udeležencevOpazovalna študija

Ohio State University Comprehensive Cancer Center, Columbus

Starost 18 in več · Ženske · Posodobljeno 6. apr. 2026 · NCT04022616

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

Vključevanje udeležencevFaza 1/2

Stefanie Spielman Comprehensive Breast Center, Columbus

Starost 18 in več · Vsi spoli · Posodobljeno 27. mar. 2026 · NCT06395519

Living Well With Advanced Breast Cancer

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

Ohio State University Comprehensive Cancer Center, Columbus

Starost 18 in več · Vsi spoli · Posodobljeno 19. mar. 2026 · NCT07227038

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Vključevanje udeležencevOpazovalna študija

Memorial Hospital, Marysville · 27 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 17. mar. 2026 · NCT06418204

Feasibility Study of CBCT for IGRT in Cancer Patients

Vključevanje udeležencev

James Outpatient Center, Columbus
Ohio State University, Brain and Spine Hospital, Columbus
The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus
in še 1

Starost 18 in več · Vsi spoli · Posodobljeno 13. mar. 2026 · NCT06681233